Journal of the American Chemical Society
Article
1H, py), 8.58 (d, 3JH−H = 5.6 Hz, 1H, py), 7.50 (s, 1H, CH of NAr), 7.48
(d, 3JH−H = 7.6 Hz, 1H, perimidine ring), 7.11−7.05 (m, 3H, Ar), 7.01−
6.93 (m, 3H, Ar), 6.87 (d, 3JH−H = 8.0 Hz, 1H, perimidine ring), 6.56 (dd,
3JH−H = 7.2 Hz, 4JH−H = 1.4 Hz, 1H, py), 6.51 (s, 1H, CH of NAr), 6.15 (d,
6.83 (t, 3JH−H = 8.2 Hz, 1H, Ar), 6.78 (d, 3JH−H = 7.0 Hz, 1H, Ar), 6.66 (t,
3JH−H = 7.3 Hz, 1H, Ar), 6.43 (t, 3JH−H = 6.5 Hz, 1H, CH of 2-Phpy), 6.33
(t, 3JH−H = 7.7 Hz, 2H, Ar), 6.23 (s, 1H, ortho CH of NAr), 6.15 (s, 1H,
para CH of NAr), 4.15 (s, 3H, NCH3), 1.76 (s, 3H, CH3 of NAr), 1.62
(s, 3H, CH3 of NAr), 1.07 (t, 3JH−H = 7.8 Hz, 9H, Si(CH2CH3)3), 0.88
J = 7.6 Hz, 1H, perimidine ring), 3.62 (s, 3H, NCH3), 2.23 (s, 3H, CH3 of
NAr), 1.93 (s, 3H, CH3 of NAr), 1.75 (s, 3H, CH3COO). 13C NMR
(100 MHz, C6D6, 30 °C): δ 192.0 (IrC), 186.4 (CO), 167.3, 157.2,
153.4, 147.5, 145.8, 137.7 (CH), 135.4, 134.8, 132.9, 132.4 (CH), 130.8,
127.3 (CH), 127.2 (CH), 127.0 (CH of NAr), 121.6, 121.4, 120.8 (CH),
119.7 (CH), 118.6 (CH of perimidine ring), 113.5, 110.8 (CH of
perimidine ring), 110.7, 105.9 (CH of perimidine ring), 41.7 (NCH3),
25.7 (OCCH3), 23.1 (CH3 of NAr), 21.2 (CH3 of NAr). IR (KBr tablet,
cm−1) v = 3448, 3058, 2959, 1632, 1604, 1595, 1584, 1526, 1469, 1441,
1426, 1383, 1325, 1222, 1139, 1087, 1037, 816, 798, 763, 677. Anal.
Calcd for C29H27IrN3O2: C, 54.27; H, 4.24; N, 6.55. Found: C, 54.53;
H, 4.12; N, 6.80.
3
(q, JH−H = 6.5 Hz, 6H, Si(CH2CH3)3). 13C NMR (100 MHz, C6D6,
30 °C): δ 183.8 (IrC), 167.0, 153.7, 150.9, 145.1, 145.0 (HCN of
2-Phpy), 142.6, 142.5, 140.3, 140.2, 140.0, 137.5, 136.8 (CH), 136.6
(CH), 136.2, 135.0, 129.9 (CH), 129.7 (CH), 128.5, 127.5, 121.1 (CH),
120.9, 120.6, 120.5, 119.6, 117.5 (CH), 106.2, 105.0 (CH), 44.3
(NCH3), 21.2 (CH3 of NAr), 20.3 (CH3 of NAr), 9.7 (Si(CH2CH3)3),
8.4 (Si(CH2CH3)3). Some carbon resonances are overlapped with C6D6
signals. 29Si NMR (85 MHz, C6D6, 35 °C): δ 6.33. IR (KBr tablet, cm−1)
v = 3447, 2944, 2869, 1634, 1603, 1585, 1477, 1422, 1380, 1345, 1316,
1089, 1004, 815, 762, 729, 661. Anal. Calcd for C37H41ClIrN3Si: C,
56.72; H, 5.27; N, 5.36. Found: C, 56.41; H, 4.90; N, 5.33.
Preparation of (XyC∧C:)(C∧N) Ir(OAc) (XyC∧C: = Cyclometalated
Perimidine-Based Carbene, C∧N = Cyclometalated N-(3-
Phenylallylidene)aniline) (7d). The synthesis of 7d was identical to
that of 7a except 1d was used as a precursor (94% yield). Bright pink
powder, mp > 270 °C (dec). 1H NMR (400 MHz, C6D6, 30 °C): δ 8.27
(d, 3JH−H = 2.4 Hz, 1H, NCH), 7.71 (s, 1H, CH of NAr), 7.60−7.55
(m, 3H, Ar), 7.14−7.10 (m, 4H, Ar), 7.05−6.93 (m, 5H, Ar), 6.84−6.75
Reaction of 2d with Et3SiD. Triethylsilane-d1 (170 mg, 1.45 mmol)
was added to benzene solution of 2d (100 mg, 1.45 × 10−1 mmol) in the
presence of 2-phenylpyridine (33.8 mg, 2.18 × 10−1 mmol) in a J-Young
tube. 2H NMR (61 MHz, C6D6, 30 °C): δ 8.06 (s, D of 8d), 7.31 (br s),
7.15 (br s), 7.08(s, D of 8d), 6.09 (br s, D of 9d), −5.68 (s, Ir−D of 8d),
−15.35 (s, Ir−D of 9d). The reaction mixture was stirred at room
temperature for 30 min, and then, CCl4 (112 mg, 7.25 × 10−1 mmol)
was added to the reaction mixture. The reaction mixture was stirred
for 20 h at ambient temperature, and all volatiles were removed under
vacuum. The bright orange powder was obtained by washing with
hexane (5 mL × 3 times) (see Figure S4, 1H NMR spectra of 8d-Cl and
8d-Cl-d3 in Supporting Information).
3
(m, 4H, Ar), 6.68 (s, 1H, CH of NAr), 5.86 (d, JH−H = 7.6 Hz, 1H,
perimidine ring), 3.18 (s, 3H, NCH3), 2.61 (s, 3H, CH3 of NAr), 2.31 (s,
3H, CH3 of NAr), 1.22 (s, 3H, CH3COO). 13C NMR (100 MHz, C6D6,
30 °C): δ 195.3 (IrC), 193.0, 186.8, 169.6 (NCH), 153.4, 152.2,
148.8, 148.4, 134.7, 134.6, 132.7, 132.1, 130.1, 129.0 (CH), 127.4, 127.3
(CH), 127.2, 126.6, 125.9 (CH), 124.0 (CH), 121.7 (CH), 121.6, 121.1
(CH), 116.2, 111.2 (CH), 110.9 (CH), 105.8 (CH of perimidine), 41.5
(NCH3), 24.5 (OCCH3), 23.1 (CH3 of NAr), 21.4 (CH3 of NAr). IR
(KBr tablet, cm−1) v = 3445, 2916, 1633, 1583, 1526, 1483, 1474, 1459,
1441, 1381, 1365, 1361, 1355, 1342, 1334, 1327, 1316, 1306, 1201,
1086, 816, 760, 697, 687, 682. Anal. Calcd for C37H33IrN3O2: C, 59.74;
H, 4.47; N, 5.65. Found: C, 59.60; H, 4.21; N, 5.49. Some carbon
resonances are overlapped with C6D6 signals.
Preparation of [(MeC∧C:)(C∧N)Ir(SiEt3)] (MeC∧C: = Cyclometa-
lated Perimidine-Based Carbene, C∧N = Cyclometalated 2-
Phenylpyridine) (10d). Triethylsilane (50.3 mg, 4.33 × 10−1 mmol)
was added to 2d (100 mg, 1.45 × 10−1 mmol) in the presence of
2-phenylpyridine (33.6 mg, 2.17 × 10−1 mmol) in 5 mL of toluene.
2-Norbornene (40.7 mg, 4.32 × 10−1 mmol) was added to the reaction
mixture sequentially. The reaction mixture was kept at room
temperature for 4 days, and all volatiles were removed under reduced
pressure. Dark red crystals were obtained in 38% yield (41 mg, 5.49 ×
10−2 mmol) by recrystallization with toluene/hexane. mp > 270 °C
(dec). 1H NMR (400 MHz, CD2Cl2, 30 °C): δ 7.66 (d, 3JH−H = 7.4 Hz,
1H, py), 7.59−7.53 (m, 3H, Ar), 7.39 (t, 3JH−H = 7.8 Hz, 2H, Ar), 7.33
(d, J = 6.8 Hz, 2H, Ar), 7.26−7.20 (m, 3H, Ar), 7.11 (t, 3JH−H = 7.9 Hz,
1H, perimidine ring), 7.07−7.02 (m, 2H, Ar), 6.95 (d, 3JH−H = 7.0 Hz,
1H, Ar), 6.67 (d, 3JH−H = 7.4 Hz, 1H, perimidine ring), 6.37 (s, 1H, CH
Characterization of [(C∧N)Ir(L)(SiEt3 )H] (C∧N = Cyclometa-
lated 2-Phenylpyridine, L = N-CH3, N-3,5-(CH3)2C6H3 Perimi-
dine-Based Carbene) (8d). Triethylsilane (5.05 mg, 4.35 × 10−2
mmol) was added to benzene solution of 2d (10.0 mg, 1.45 × 10−2
mmol) in the presence of 2-phenylpyridine-d9 (2.38 mg, 1.45 × 10−2
mmol) in a J-Young tube. 1H NMR (400 MHz, C6D6, 30 °C): δ 8.29 (d,
3
3JH−H = 5.6 Hz, 1H, py), 8.03 (d, JH−H = 7.3 Hz, 1H, Ar), 7.66 (d,
3JH−H = 7.7 Hz, 1H, perimidine ring), 7.33 (td, 3JH−H = 7.2 Hz, 4JH−H
=
of NAr), 6.00 (d, 3JH−H = 7.7 Hz, 1H, perimidine ring), 3.45 (d, 2JH−H
=
8.5 Hz, 1H, NCH2Ir), 3.39 (d, 2JH−H = 8.5 Hz, 1H, NCH2Ir), 2.50 (s,
3H, CH3 of NAr), 2.32 (s, 3H, CH3 of NAr), 0.57 (t, 3JH−H = 7.7 Hz, 9H,
Si(CH2CH3)3), 0.40 (q, 3JH−H = 7.8 Hz, 6H, Si(CH2CH3)3). 13C NMR
(100 MHz, CD2Cl2, 30 °C): δ 189.0, 172.4, 169.3, 155.8, 151.1, 143.3,
142.5, 141.9, 141.2, 138.9, 138.9, 136.8, 135.5, 131.1, 128.9, 128.8, 128.0,
127.6, 127.5, 123.0, 122.9, 121.7, 120.9, 120.5, 119.7, 119.2, 118.0, 106.5,
101.4, 21.6, 21.5, 8.9, 7.9, 7.3. 29Si NMR (85 MHz, C6D6, 30 °C): δ 7.02.
IR (KBr tablet, cm−1) v = 3451, 3047, 2925, 2868, 1630, 1583, 1526,
1471, 1421, 1380, 1340, 1313, 1216, 1162, 1000, 815, 765, 750, 732.
Anal. Calcd for C37H40IrN3Si: C, 59.49; H, 5.40; N, 5.62. Found: C,
59.53; H, 5.41; N, 5.79.
1.3 Hz, 1H, perimidine ring), 7.28 (s, 1H, ortho CH of NAr), 7.25 (d, J =
8.9 Hz, 1H, Ar), 7.20−7.15 (m, 2H, Ar), 7.15−7.09 (m, 2H, Ar), 7.01−
6.96 (m, 1H, Ar), 6.90 (m, 1H, Ar, overlapped with CH of NAr), 6.88 (s,
1H, ortho CH of NAr), 6.51 (s, 1H, para CH of NAr), 6.42 (d, 3JH−H
=
7.5 Hz, 1H, perimidine ring), 6.26 (dd, 3JH−H = 7.3 Hz, 4JH−H = 1.3 Hz,
3
1H, py), 6.18 (d, JH−H = 8.0 Hz, 1H, perimidine ring), 3.99 (s, 3H,
NCH3), 2.16 (s, 3H, CH3 of NAr), 1.22 (s, 3H, CH3 of NAr), 0.99−0.95
(m, 9H, Si(CH2CH3)3, overlapped with free HSiEt3) 0.79−0.73 (m, 6H,
Si(CH2CH3)3, overlapped with free Et3SiOAc), −5.55 (s, 1H, Ir−H).
29Si NMR (85 MHz, C6D6, 30 °C): δ 5.35.
Preparation of [(C∧N)Ir(L)(SiEt3 )Cl] (C∧N = Cyclometalated 2-
Phenylpyridine, L = N-CH3, N-3,5-(CH3)2C6H3 Perimidine-Based
Carbene) (8d-Cl). Triethylsilane (50.3 mg, 4.33 × 10−1 mmol) was
added to 2d (100 mg, 1.45 × 10−1 mmol) in the presence of
2-phenylpyridine (33.6 mg, 2.17 × 10−1 mmol) in 8 mL of toluene. The
reaction mixture was stirred at room temperature for 30 min, and then,
CCl4 (111 mg, 7.22 × 10−1 mmol) was added to the reaction mixture.
The reaction mixture was stirred for 20 h at ambient temperature, and all
volatiles were removed under vacuum. The orange powder was washed
by hexane (5 mL × 3 times) and was dried under vacuum. Bright orange
powder was obtained in 69% yield (78.3 mg, 1.00 × 10−1 mmol). mp >
Preparation of [(C∧N)Ir(L)(SiMe2 Bn)Cl] (C∧N = Cyclometa-
lated 2-Phenylpyridine, L = N-CH3, N-3,5-3,5-(CH3)2C6H3
Perimidine-Based Carbene) (11d-Cl). A similar procedure to that
for 8d-Cl was employed without excess of 2-phenylpyridine. The
mixture was purified by silica-column chromatography (46% yield). Red
powder, mp > 270 °C (dec). 1H NMR (400 MHz, C6D6, 30 °C): δ 9.11
(d, 3JH−H = 7.4 Hz, 1H, py), 7.98 (d, 3JH−H = 5.6 Hz, 1H, Bn), 7.91 (s,
1H, CH of NAr), 7.35 (t, 3JH−H = 7.4 Hz, 1H, Ar), 7.14−1.11 (m, 3H,
Ar), 7.09−7.07 (m, 3H, Ar), 7.05−7.03 (m, 3H, Ar), 6.97 (t, 3JH−H = 7.1
Hz, 1H, Ar), 6.85 (t, 3JH−H = 8.0 Hz, 1H, Ar), 6.78 (d, 3JH−H = 8.1 Hz,
1H, Ar), 6.67 (t, 3JH−H = 7.7 Hz, 1H, Bn), 6.34 (d, 3JH−H = 7.5 Hz, 1H,
Ar), 6.24 (d, 3JH−H = 7.8 Hz, 1H, perimidine ring), 6.16 (s, 1H, CH of
NAr), 6.11 (s, 1H, CH of NAr), 5.89 (t, 3JH−H = 6.2 Hz, 1H, Bn), 4.09
270 °C (dec). 1H NMR (400 MHz, C6D6, 30 °C): δ 10.08 (d, 3JH−H
=
5.7 Hz, 1H, HCN of 2-Phpy), 8.13 (s, 1H, ortho CH of NAr), 7.22 (d,
3JH−H = 7.7 Hz, 1H, perimidine ring), 7.17−7.13 (m, 1H, Ar, overlapped
3
2
with C6D6), 7.08 (d, JH−H = 8.3 Hz, 1H, Ar), 7.04 (m, 2H, Ar), 6.94
(s, 3H, NCH3), 2.74 (d, JH−H = 13.7 Hz, 1H, Si(CH2Ph)Me2), 2.57
2
(d, 3JH−H = 8.3 Hz, 1H, CH of 2-Phpy), 6.88 (t, 3JH−H = 7.3 Hz, 1H, Ar),
(d, JH−H = 13.7 Hz, 1H, Si(CH2Ph)Me2), 1.68 (s, 3H, CH3 of NAr),
J
dx.doi.org/10.1021/ja406519u | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX